| http://www.w3.org/ns/prov#value | - Sobi filed the application after Dr. Raphaela Goldbach-Mansky of NIH???s National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and colleagues found in a clinical trial that the drug was able to improve disease symptoms including rash, joint pain and headaches.
|
